We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Johnson, D. A. W. (1978) Prevalence and treatment of drug induced extrapyramidal symptoms. British Journal of Psychiatry, 132, 27–30.CrossRefGoogle Scholar
Johnstone, E. C., Crow, J. J., Ferrier, I. N.et al (1983) Adverse effects of anticholinergic medication on positive schizophrenic symptoms. Psychological Medicine, 13, 513–527.CrossRefGoogle ScholarPubMed
McClelland, H. A., Blessed, G., Bhate, S.et al (1974) The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients. British Journal of Psychiatry, 124, 151–159.CrossRefGoogle ScholarPubMed
McDonal, C. E. (1981) Haloperidol and laryngeal dystonia. American Journal of Psychiatry, 138, 1262–1263.CrossRefGoogle Scholar
Moss, H. B. & Green, A. (1982) Neuroleptic associated dysphagia confirmed by oesophageal manometry. American Journal of Psychiatry, 139, 515–516.Google Scholar
Van Putten, T. (1974) Why do schizophrenic patients refuse to take their drugs?Archives of General Psychiatry, 31, 67–72.CrossRefGoogle ScholarPubMed
eLetters
No eLetters have been published for this article.